Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector

Rajagopal Ramesh, Tomoyuki Saeki, Nancy Smyth Templeton, Lin Ji, L. Clifton Stephens, Isao Ito, Deborah R. Wilson, Zheng Wu, Cynthia D. Branch, John D. Minna, Jack A. Roth

Research output: Contribution to journalArticle

163 Scopus citations

Abstract

Delivery of therapeutic genes to disseminated tumor sites has been a major challenge in the field of cancer gene therapy due to lack of an efficient vector delivery system. Among the various vectors currently available, liposomes have shown promise for the systemic delivery of genes to distant sites with minimal toxicity. In this report, we describe an improved extruded DOTAP:cholesterol (DOTAP:Chol) cationic liposome that efficiently delivers therapeutic tumor suppressor genes p53 and FHIT, which are frequently altered in lung cancer, to localized human primary lung cancers and to experimental disseminated metastases. Transgene expression was observed in 25% of tumor cells per tumor in primary tumors and 10% in disseminated tumors. When treated with DOTAP: Chol-p53 and -FHIT complex, significant suppression was observed in both primary (P < 0.02) and metastatic lung tumor growth (P < 0.007). Furthermore, repeated multiple treatments revealed a 2.5-fold increase in gene expression and increased therapeutic efficacy compared to single treatment. Finally, animal survival experiments revealed prolonged survival (median survival time: 76 days, P < 0.001 for H1299; and 96 days, P = 0.04 for A549) when treated with liposome-p53 DNA complex. Our findings may be of importance in the development of treatments for primary and disseminated human lung cancers.

Original languageEnglish (US)
Pages (from-to)337-350
Number of pages14
JournalMolecular Therapy
Volume3
Issue number3
DOIs
StatePublished - Jan 1 2001

Keywords

  • FHIT
  • Gene therapy
  • Intratumoral
  • Intravenous
  • Liposome
  • Lung cancer
  • Tumor suppressor
  • p53

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector'. Together they form a unique fingerprint.

  • Cite this

    Ramesh, R., Saeki, T., Smyth Templeton, N., Ji, L., Stephens, L. C., Ito, I., Wilson, D. R., Wu, Z., Branch, C. D., Minna, J. D., & Roth, J. A. (2001). Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector. Molecular Therapy, 3(3), 337-350. https://doi.org/10.1006/mthe.2001.0266